1. Home
  2. ODTX vs LCID Comparison

ODTX vs LCID Comparison

Compare ODTX & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

N/A

Current Price

$2.50

Market Cap

1.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
ODTX
LCID
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
ODTX
LCID
Price
$16.85
$2.50
Analyst Decision
Strong Buy
Hold
Analyst Count
8
11
Target Price
★ $34.67
$6.06
AVG Volume (30 Days)
291.0K
★ 12.1M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $595,271,000.00
Revenue This Year
N/A
$11.08
Revenue Next Year
N/A
$112.41
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$15.10
$2.37
52 Week High
$29.05
$14.26

Technical Indicators

Market Signals
Indicator
ODTX
LCID
Relative Strength Index (RSI) 36.09 33.05
Support Level $15.73 $2.37
Resistance Level $19.60 $4.36
Average True Range (ATR) 1.69 0.32
MACD -0.19 -0.04
Stochastic Oscillator 6.10 0.29

Price Performance

Historical Comparison
ODTX
LCID

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

Share on Social Networks: